webinar register page

Webinar banner
Application of Microfluidic Modulation Spectroscopy (MMS) for Characterizing the Secondary Structure of Mixed Food Protein Complexes
During this FREE webinar, academic and industrial researchers within the food science and biopharmaceutical fields will learn about:

• The significance of changes in protein secondary structure due to downstream processing, such as enzymatic cross-linking
• Why traditional spectroscopic techniques cannot accurately detect these subtle changes
• The advantages of performing structural analysis on high-concentration samples
• The fundamentals of Microfluidic Modulation Spectroscopy and its applications in biopharmaceutical development

Register today to discover how MMS provides reliable and reproducible HOS data that is not attainable by other spectroscopic methods while saving time and expense in food or drug development research.

Apr 25, 2023 11:00 AM in Eastern Time (US and Canada)

* Required information
Loading
Register

Speakers

Woojeong Kim
PhD Candidate @University of New South Wales
Ms. Woojeong Kim is a PhD candidate in the Food Science and Technology program at the UNSW Sydney under the supervision of Prof. Cordelia Selomulya. Her research primarily focuses on processing strategies, exploring new food materials, and particle technology in the food and beverage sector. Her PhD project is on encapsulating bioactive compounds using proteins, polysaccharides, and their combinations in food. Particularly, she investigates improving plant protein functionality using dairy/plant protein blends, focusing on protein interaction, structural modification, and food application.
Valerie Collins, PhD
Applications Manager @RedShiftBio
Dr. Valerie Collins joined RedShiftBio over four years ago and her experience with Microfluidic Modulation Spectroscopy began prior to that, as the first external beta tester of the original AQS3pro system. Valerie's research background primarily involves structural and spectroscopic characterization of proteins and peptides, focusing on amyloidosis. Dr. Collins has acquired a wealth of biophysical characterization experience throughout her academic and professional endeavours and she now leads the internal and external field applications team at RedShiftBio and oversees all proof-of-concept studies worldwide.

Share via Email

All fields are required
 

Switch Time Zone